Yomade O - Search Results

1

Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.

Tober R, Schnetzke U, Fleischmann M, Yomade O, Schrenk K, Hammersen J, Glaser A, Thiede C, Hochhaus A, Scholl S. Tober R, et al. Among authors: yomade o. J Cancer Res Clin Oncol. 2023 Apr;149(4):1569-1583. doi: 10.1007/s00432-022-03995-2. Epub 2022 May 18. J Cancer Res Clin Oncol. 2023. PMID: 35583829 Free PMC article.

2

Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia.

Yomade O, Spies-Weisshart B, Glaser A, Schnetzke U, Hochhaus A, Scholl S. Yomade O, et al. Ann Hematol. 2013 Aug;92(8):1071-7. doi: 10.1007/s00277-013-1734-0. Epub 2013 Apr 5. Ann Hematol. 2013. PMID: 23558906

3

Polymorphisms of Toll-like receptors (TLR2 and TLR4) are associated with the risk of infectious complications in acute myeloid leukemia.

Schnetzke U, Spies-Weisshart B, Yomade O, Fischer M, Rachow T, Schrenk K, Glaser A, von Lilienfeld-Toal M, Hochhaus A, Scholl S. Schnetzke U, et al. Among authors: yomade o. Genes Immun. 2015 Jan-Feb;16(1):83-8. doi: 10.1038/gene.2014.67. Epub 2014 Nov 27. Genes Immun. 2015. PMID: 25427560

4

The risk of infections in multiple myeloma before and after the advent of novel agents: a 12-year survey.

Brioli A, Klaus M, Sayer H, Scholl S, Ernst T, Hilgendorf I, Scherag A, Yomade O, Schilling K, Hochhaus A, Mügge LO, von Lilienfeld-Toal M. Brioli A, et al. Among authors: yomade o. Ann Hematol. 2019 Mar;98(3):713-722. doi: 10.1007/s00277-019-03621-1. Epub 2019 Jan 24. Ann Hematol. 2019. PMID: 30680505

5

Melphalan 200 mg/m² does not increase toxicity and improves survival in comparison to reduced doses of melphalan in multiple myeloma patients.

Brioli A, Vom Hofe F, Rucci P, Ernst T, Yomade O, Hilgendorf I, Scholl S, Sayer H, Mügge LO, Hochhaus A, von Lilienfeld-Toal M. Brioli A, et al. Among authors: yomade o. Bone Marrow Transplant. 2021 May;56(5):1209-1212. doi: 10.1038/s41409-020-01170-0. Epub 2020 Dec 9. Bone Marrow Transplant. 2021. PMID: 33299059

6

Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort.

Brioli A, Nägler TM, Yomade O, Rüthrich MM, Scholl S, Frietsch JJ, Hilgendorf I, Ernst T, Sayer HG, Hochhaus A, Mügge LO, von Lilienfeld-Toal M. Brioli A, et al. Among authors: yomade o. Oncol Res Treat. 2022;45(9):494-503. doi: 10.1159/000525493. Epub 2022 Jun 15. Oncol Res Treat. 2022. PMID: 35705004

7

Mutations in the plasma cell clone identify mechanism of polyneuropathy in a case of POEMS syndrome associated with Castleman disease and multiple myeloma.

Brioli A, Wyrwa A, Rüddel U, Yomade O, Lindig U, Franz W, Wacker HH, Gaßler N, Schweyer S, Chung HY, Axer H, Witte OW, Hochhaus A, Schrenk KG. Brioli A, et al. Among authors: yomade o. Ann Hematol. 2023 Jan;102(1):239-242. doi: 10.1007/s00277-022-05032-1. Epub 2022 Nov 19. Ann Hematol. 2023. PMID: 36401620 Free PMC article. No abstract available.

8

[Dysphagia at Neutropenia of Unknown Primary].

Granitzka T, Inhestern JM, Yomade O, Guntinas-Lichius O. Granitzka T, et al. Among authors: yomade o. Laryngorhinootologie. 2016 Dec;95(12):851-852. doi: 10.1055/s-0042-117637. Epub 2016 Nov 16. Laryngorhinootologie. 2016. PMID: 27852094 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page